Cargando…

Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis

Multiple sclerosis (MS) is a chronic immune-mediated disease with a neurodegenerative component of the central nervous system. Immunomodulatory therapy can increase the risk of infection, which is a particular risk for MS patients. Therefore, a complete vaccination status is of utmost importance as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langhorst, Silvan Elias, Frahm, Niklas, Hecker, Michael, Mashhadiakbar, Pegah, Streckenbach, Barbara, Baldt, Julia, Heidler, Felicita, Zettl, Uwe Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146089/ https://www.ncbi.nlm.nih.gov/pubmed/35629100 http://dx.doi.org/10.3390/jpm12050677

Ejemplares similares

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
por: Heidler, Felicita, et al.
Publicado: (2022)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
por: Haker, Marie-Celine, et al.
Publicado: (2023)

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023)

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
por: Hecker, Michael, et al.
Publicado: (2022)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Diphtheria, Tetanus, and Pertussis Immunity in Indian Adults and Immunogenicity of Td Vaccine
por: Kulkarni, Prasad S., et al.
Publicado: (2011)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

Impact of childhood and maternal vaccination against diphtheria, tetanus, and pertussis in Colombia
por: Hoyos, Maria Cristina, et al.
Publicado: (2021)

Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000–2016: a spatial and temporal modelling study
por: Mosser, Jonathan F, et al.
Publicado: (2019)

Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
por: Isenhour, Cheryl J., et al.
Publicado: (2022)

Coverage with Tetanus, Diphtheria, and Acellular Pertussis Vaccine and Influenza Vaccine Among Pregnant Women — Minnesota, March 2013–December 2014
por: Barber, Alexandra, et al.
Publicado: (2017)

153. The Effect of Timing of Tetanus–Diphtheria and Pertussis Vaccine Administration in Pregnancy on The Avidity of Pertussis Antibodies
por: Raya, Bahaa Abu, et al.
Publicado: (2018)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Low Influenza, Pneumococcal and Diphtheria–Tetanus–Poliomyelitis Vaccine Coverage in Patients with Primary Sjögren’s Syndrome: A Cross-Sectional Study
por: Jacques, Morel, et al.
Publicado: (2019)

Tetanus, Diphtheria, Pertussis Vaccination Coverage Before, During, and After Pregnancy — 16 States and New York City, 2011
por: Ahluwalia, Indu B., et al.
Publicado: (2015)

Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register
por: Voss, Sidsel Skou, et al.
Publicado: (2020)

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents
por: Vesikari, Timo, et al.
Publicado: (2016)

How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groups
por: Lungarde, Karine, et al.
Publicado: (2013)

Awareness, Knowledge, and Coverage of Vaccination Against Tetanus, Diphtheria, and Pertussis Among Medical Students of Karachi: A Cross-sectional Analysis
por: Siddiqui, Amna A, et al.
Publicado: (2019)

Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines
por: Rosen, Jennifer B, et al.
Publicado: (2005)

Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies
por: Florea, Ana, et al.
Publicado: (2022)

Exploring the genetic landscape of diphtheria, tetanus and pertussis vaccination-associated seizures or subsequent epilepsies
por: Negi, Sandeep, et al.
Publicado: (2022)

Vaccination with Tetanus, Diphtheria, and Acellular Pertussis Vaccine of Pregnant Women Enrolled in Medicaid — Michigan, 2011–2013
por: Housey, Michelle, et al.
Publicado: (2014)

Attitudes of US Obstetricians Toward a Combined Tetanus-Diphtheria-Acellular Pertussis Vaccine for Adults
por: Clark, Sarah J., et al.
Publicado: (2006)

Pharmacists’ Attitudes and Practices Regarding Tetanus, Diphtheria and Pertussis (Tdap) Vaccination in Pregnancy and Surrounding Newborns
por: Echtenkamp, Christine A, et al.
Publicado: (2018)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
por: Kumar, Vivek, et al.
Publicado: (2018)

Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV
por: Nunes, Marta C., et al.
Publicado: (2023)

Association of Diphtheria-Tetanus–Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children
por: Rane, Madhura S., et al.
Publicado: (2021)

Access to skilled attendant at birth and the coverage of the third dose of diphtheria-tetanus-pertussis vaccine across 14 West African countries – an equity analysis
por: Alhassan, Jacob Albin Korem, et al.
Publicado: (2020)

Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care
por: Masseria, Cristina, et al.
Publicado: (2015)

Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Liang, Jennifer L., et al.
Publicado: (2018)

Lichen planus following tetanus–diphtheria–acellular pertussis vaccination: A case report and review of the literature
por: Rosengard, Heather C, et al.
Publicado: (2018)

Optic neuritis following diphtheria, tetanus, pertussis, and inactivated poliovirus combined vaccination: a case report
por: O’Brien, Preston, et al.
Publicado: (2018)

Associated Factors for Dropout of First Vs Third Doses of Diphtheria Tetanus Pertussis (DPT) Vaccination in Nepal
por: Thapa, Kanchan, et al.
Publicado: (2021)

Diphtheria-tetanus-pertussis (DTP) vaccination: understanding the perspectives and expectations of parents and healthcare professionals in France and India
por: Bakhache, Pierre, et al.
Publicado: (2021)

Half-life Estimation of Pertussis-Specific Maternal Antibodies in (Pre)Term Infants After In-Pregnancy Tetanus, Diphtheria, Acellular Pertussis Vaccination
por: Embacher, Stefan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i3u4183j75o5tp2m2q6nokqkjk